Effect of Raha syrup on the severity of dependence, stress, anxiety, depression and craving and serum cortisol and serotonin levels in opium tincture addicts

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20151228025732N62

Enrollment

Registered

2021-01-23

Start date

2021-01-20

Completion date

Unknown

Last updated

2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Addiction. Alcoholism and drug addiction in family

Interventions

Intervention 1: Intervention group: In this group, 21 addicts are treated simultaneously with opium tincture and Raha syrup for 9 weeks. Raha syrup (Isfahan Goldaru Pharmaceutical Company), two tables

Eligibility

Sex/Gender

Male

Age

45 Years to No maximum

Inclusion criteria

Inclusion criteria: No musculoskeletal injuries No history of mental, cardiovascular, thyroid and gastrointestinal diseases No history of infectious diseases, diabetes, AIDS, hepatitis Have at least one-year History of opium addiction Do not use other narcotic during the study period Age over 45 years

Exclusion criteria

Exclusion criteria: Observation of depressive disorders and severe anxiety in individuals

Design outcomes

Primary

Measure	Time frame
Severity of dependence. Timepoint: Before and after the intervention. Method of measurement: Leeds Dependency Questionnaire.;Stress. Timepoint: Before and after the intervention. Method of measurement: Lovebond Questionnaire.;Intensity of craving. Timepoint: Before and after the intervention. Method of measurement: Visual Analogue Scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHosein Miladi gorji

Semnan University of Medical Sciences

are20935@yahoo.com+98 23 3345 1336

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026